COVID-19 Vaccines

The JAMA Network sat down with Dr. Carlos del Rio from Emory University on January 27, 2021 to answer questions about COVID-19 vaccines. Click the video below. For additional JAMA videos, visit their youtube channel. For more information about COVID-19 research and updates, visit the links in the COVID-10 Resource Portal.


COVID-19 Basics

Learn the science-based basics about COVID-19 transmission, current diagnostics, and the future of treatment with Dr. Carlos del Rio and Dr. Dennis Liotta from Emory University.

 
 

COVID-19 Basics and Convalescent Plasma Therapy

What is the current understanding of COVID-19 infections in children?

What are the implications of in-person schooling for children and adolescents?

What are the long term complications of COVID-19?

How useful is Remdesivir for treatment?

Can people be infected with COVID 19 for a long time?

Will SARS-CoV-2 become less threatening over time?

How long will it take to develop COVID 19 immunity after a vaccination?

What role will memory T-cell immunity play in our susceptibility to COVID 19?

Will COVID 19 vaccinations require booster shots?

What impact will Flu season have on SARS-CoV-2 treatment?

 

 
 

Watch the full interview


 

Biographies:

Carlos del Rio, MD is a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine and Professor of Global Health and Epidemiology at the Rollins School of Public Health. He is also Executive Associate Dean for Emory at Grady, PI and co-Director of the Emory Center for AIDS Research (CFAR) and co-PI of the Emory-CDC HIV Clinical Trials Unit and the Emory Vaccine Treatment and Evaluation Unit.

Dennis Liotta, PhD, serves as Executive Director of the Emory Institute for Drug Development and Samuel Candler Dobbs Professor in the Department of Chemistry at Emory University. Dr. Liotta is recognized as one of the premier discoverers of novel therapeutics in the United States, having been the inventor of record for several clinically important antivirals and associated with the invention of ten FDA approved therapeutics.